Factors Influencing Clinical Pregnancy Rates After Myomectomy Among Infertile Women: A Single Center Retrospective Study
PDF
Cite
Share
Request
Original Article
P: 222-227
September 2018

Factors Influencing Clinical Pregnancy Rates After Myomectomy Among Infertile Women: A Single Center Retrospective Study

Med Bull Haseki 2018;56(3):222-227
1. Sağlık Bilimleri Üniversitesi, Ankara Dr. Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Kliniği, Ankara, Türkiye
No information available.
No information available
Received Date: 14.02.2018
Accepted Date: 20.04.2018
Publish Date: 20.09.2018
PDF
Cite
Share
Request

ABSTRACT

Aim:

To determine the clinical pregnancy rates after myomectomy in infertile women who underwent surgery due to myoma uteri and to investigate the clinical factors affecting outcomes.

Methods:

This retrospective single-centered study included infertile patients who underwent intramural and/or subserousal uterine myomectomy in the infertility clinic at our hospital between February 2012 and October 2014. Data were obtained from the hospital records and patients’ files. Age, body mass index, physical features of myomas (diameter, number, structure, and location), surgical treatment methods used and postoperative pregnancy status were recorded for each patient separately.

Results:

A total of 211 infertile women who met the inclusion criteria for this study and who underwent myomectomy due to myoma uteri were included. The mean myoma diameter was 7.3±4.4 cm and intramural tumors (49.8%) were the most commonly observed type. Laparoscopic myomectomy was performed in 186 patients (88.1%) and laparoscopic in 25 patients (11.9%). The clinical pregnancy rate was calculated as 19.9% (42/211), while 28.6% (12/42) of pregnancies resulted in live birth and 71.4% (30/42) in spontaneous abortion. The mean age of the pregnant and non-pregnant patients was 33.2±5.6 and 36.8±5.8 years, respectively. The mean body mass index was 25.9±3.5 and 28.8±4.8 kg/m2, respectively (p<0.001). There was no statistically significant difference between the groups in terms of myoma diameter, number, myometrial location, uterine location, and operation method (p>0.05).

Conclusion:

The most important factors for predicting pregnancy in patients who undergo surgery due to myoma and infertility are female age and body mass index. It seems that myoma diameter, number, myometrial location, uterine location and method of surgery are not significant factors in predicting pregnancy.

References

1
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7.
2
Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-8.
3
Olive DL, Pritts EA. Fibroids and reproduction. Semin Reprod Med 2010;28:218-27.
4
Bendifallah S, Brun JL, Fernandez H. [Myomectomy for infertile women: the role of surgery]. J Gynecol Obstet Biol Reprod (Paris) 2011;40:885-901.
5
Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy--a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2009;145:14-21.
6
Kaminski P, Gajewska M, Wielgos M, et al. Laparoscopic treatment of uterine myomas in women of reproductive age. Neuro Endocrinol Lett 2008;29:163-7.
7
Marchionni M, Fambrini M, Zambelli V, Scarselli G, Susini T. Reproductive performance before and after abdominal myomectomy: a retrospective analysis. Fertil Steril 2004;82:154-9.
8
Saleh S, Issa A. Reproductive outcome after abdominal myomectomy. J Obstet Gynaecol 2000;20:282.
9
Gavai M, Berkes E, Lazar L, et al. Factors affecting reproductive outcome following abdominal myomectomy. J Assist Reprod Genet 2007;24:525-31.
10
Desai P, Patel P. Fibroids, infertility and laparoscopic myomectomy. J Gynecol Endosc Surg 2011;2:36-42.
11
Çinar M, Tokmak A, Güzel AI, et al. Association of clinical outcomes and complications with obesity in patients who have undergone abdominal myomectomy. J Chin Med Assoc 2016;79:435-9.
12
Kotani Y, Tobiume T, Fujishima R, et al. Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res 2018;44:298-302.
13
Berek JS. Berek and Novak’s gynecology. 15th ed. Lippincott Williams and Willkins, New Delhi; 2012.
14
Palomba S, Zupi E, Falbo A, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril 2007;88:933-41.
15
Edmonds DK. Dewhurst’s Textbook of obstetrics and gynaecology. 7th ed. Blackwell publishing, USA; 2007.
16
John O. Schorge Williams Gynecology. 1st ed. Dallas, Texas; 2008.
17
Taylor E, Gomel V. The uterus and infertility. Fertil Steril 2008;89:1-16.
18
Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91:1215-23.
19
Li TC, Mortimer R, Cooke ID. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 1999;14:1735-40.
20
Bulletti C, DE Ziegler D, Levi Setti P, et al. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci 2004;1034:84-92.
21
Shin DG, Yoo HJ, Lee YA, Kwon IS, Lee KH. Recurrence factors and reproductive outcomes of laparoscopic myomectomy and minilaparotomic myomectomy for uterine leiomyomas. Obstet Gynecol Sci 2017;60:193-9.
22
Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril 2016;9:424-35.
23
Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 2000;108:791-3.
24
Samadi AR, Lee NC, Flanders WD, Boring JR 3rd, Parris EB. Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health 1996;86:858-62.
25
Terry KL, De Vivo I, Hankinson SE, Spiegelman D, Wise LA, Missmer SA. Anthropometric characteristics and risk of uterine leiomyoma. Epidemiology 2007;18:758-63.
26
Wise LA, Palmer JR, Spiegelman D, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 2005;16:346-54.
27
Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study. Br J Obstet Gynaecol 1996;103:909-14.
28
Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology 1996;7:440-2.
29
Wang D, DuBois RN. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett 2008;267:197-203.